Concorde Asset Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,238
Closed -$216K 159
2021
Q4
$216K Sell
1,238
-260
-17% -$43.3K 0.13% 151
2021
Q3
$248K Sell
1,498
-596
-28% -$103K 0.14% 162
2021
Q2
$377K Sell
2,094
-7
-0.3% -$1.28K 0.21% 118
2021
Q1
$405K Buy
2,101
+321
+18% +$61.8K 0.23% 103
2020
Q4
$359K Sell
1,780
-170
-9% -$35.2K 0.2% 93
2020
Q3
$410K Buy
+1,950
New +$434K 0.23% 104

Other funds holding CLX

Concorde Asset Management's CLX Position: Q1 2022 in Review

Concorde Asset Management sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,238 shares — an estimated $216K sold.

Concorde Asset Management first reported a position in CLX in Q3 2020 and held it in 6 quarters. The position peaked at $410K in Q3 2020. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Concorde Asset Management reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Concorde Asset Management sold 1,238 Clorox shares in Q1 2022, an estimated $216K.
  • Concorde Asset Management first reported a position in Clorox in Q3 2020 and held it in 6 quarters.
  • Concorde Asset Management's Clorox position peaked at $410K in Q3 2020.
  • 1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Concorde Asset Management's 13F filing for Q1 2022, filed 22 Apr 2022.